Workflow
反腐!中纪委连打三虎
21世纪经济报道·2025-07-30 12:38

Core Viewpoint - The article highlights the recent disciplinary actions taken by the Central Commission for Discipline Inspection (CCDI) against three senior officials, emphasizing the ongoing anti-corruption efforts within the Chinese government and the increasing severity of these measures since the 20th National Congress of the Communist Party of China [1][2]. Group 1: Disciplinary Actions - Three senior officials were expelled from the Party and public office for serious violations of discipline and law: Zhou Xi'an, Wang Zhonghe, and Chen Shifei [1][2]. - Zhou Xi'an, former Vice Chairman of the Anhui Provincial Political Consultative Conference, was found guilty of corruption and abuse of power, engaging in power-for-money transactions [1][8]. - Wang Zhonghe, former Vice Chairman of the Inner Mongolia Autonomous Region Political Consultative Conference, was accused of using his position for personal gain and engaging in bribery [2][12]. - Chen Shifei, former Deputy Director of the National Medical Products Administration, was implicated in using his authority to benefit others in the pharmaceutical sector and was also involved in corrupt practices [2][22]. Group 2: Background of Officials - Zhou Xi'an had a long career in various central government departments before his appointment in local government, where he served in multiple leadership roles [6][7]. - Wang Zhonghe had over 40 years of experience in Inner Mongolia, holding significant positions in local governance, including mayoral roles in major cities [14][15]. - Chen Shifei had a 39-year career in drug management, transitioning from provincial to national oversight, and was the first senior official from the National Medical Products Administration to be investigated [21][22]. Group 3: Implications for the Pharmaceutical Sector - The CCDI has intensified its focus on corruption within the pharmaceutical industry, identifying it as a key area for reform due to its susceptibility to corrupt practices [23][24]. - Recent investigations have led to the downfall of several high-ranking officials in provincial drug supervision agencies, indicating a broader crackdown on corruption in this sector [24].